Skip to content
Insider tapeLive · 5:07 PM ET
My stocks

Universal Health Services (UHS) insider trading

Insider activity, historical context and SEC filings · data through Nov 20, 2026

Health CareMedical Care FacilitiesUHS

Closing price · Nov 19, 2026 $175.66 -5.6% on the day · -22.6% over 12 months 52-week range $141.00 – $243.12
Get UHS alerts
Open-market purchases0 insidersno buys · last 12 months
Insiders selling1last 12 months
Reported sales$128K0 of 5 recent sales pre-planned (10b5-1)
In 15 seconds

No open-market insider buying in the last 12 months. Selling alone is common (taxes, diversification) and isn't treated as a signal here.

Label: Net selling · based on open-market trades (codes P and S), last 12 months. Not a rating or advice.
Latest open-market trade

Sale Elliot J. Md Mba Sussman, Director sold 356 shares at $193.37 ($69K).

Trade date
Mar 13, 2026
Disclosed to the SEC
Mar 13, 2026
Type
Sale (code S)

Read the original SEC filing ↗All UHS insider trades ↓

Insiders have two business days to report a trade to the SEC, so filings (and our alerts) always come after the trade, never in real time.

UHS insider transactions (Form 4)

Open-market purchases and sales. 80 grants, option exercises and tax withholdings are not shown.

Filed Insider Type Shares Price Value Since Score
Mar 13SEC Elliot J. Md Mba SussmanDirector Sell 3566,113 held (−6%) $193.37 $69K -9.2% —
Mar 13SEC Elliot J. Md Mba SussmanDirector Sell 3186,113 held (−5%) $186.35 $59K -5.7% —
Nov 12SEC Warren J. NimetzDirector Sell 3,6758,623 held (−30%) $223.28 $821K -21.3% —
Nov 12SEC Warren J. NimetzDirector Sell 1428,481 held (−2%) $223.96 $32K -21.6% —
Oct 30SEC Elliot J. Md Mba SussmanDirector Sell 9656,113 held (−14%) $225.70 $218K -22.2% —
Historical context

Similar past setups: not applicable. UHS has had no open-market insider purchases in the last 12 months, so there's no buying setup to compare with history. When insiders buy, this section shows how 6,290 similar past buys did over 90 days. How we calculate this →

Play with UHS in the Research Lab

UHS has no open-market insider buys in the last 12 months. Try the tools with any setup.

All tools →

Quick backtest: did buys like this beat the market?

Insiders buying
CEO or CFO
Dollar size
Stock before

Tap a setting to see how 6,290 past insider buys did.

Open the full Backtester →

Share price and insider trades

UHS closeInsider buyInsider sale
100150200250DecJan 2026FebMarAprMayJunJulAugSepOctNovEEarnings release filed 2026-02-26EEarnings release filed 2026-04-28EEarnings release filed 2026-07-28Sold $59,258 on 2026-03-11 · Elliot J. Md Mba SussmanSold $68,841 on 2026-03-13 · Elliot J. Md Mba Sussman
Bought, 12 months$0
Sold, 12 months$128K
Insiders buying0
Insiders selling1

Universal Health Services insider trading at a glance (Nov 20, 2026): in the past 12 months, 0 insiders bought $0 and 1 sold $128K of UHS stock on the open market; P/E 8.3 vs. a sector median of 25.0.

By InsiderPrint Research Desk · Updated · Sources: SEC EDGAR Form 4 filings, FINRA short-sale volume · How we calculate this

UHS insider buying and selling by quarter

Open-market purchases (green, above the line) and sales (red, below), by trade date.

Q4 2025: $1.1M sold (3 trades)Q4 2025Q1 2026: $128K sold (2 trades)Q1 2026Q2 2026Q3 2026Q4 2026
QuarterBoughtPurchasesSoldSales
Q4 2026—0—0
Q3 2026—0—0
Q2 2026—0—0
Q1 2026—0$128K2
Q4 2025—0$1.1M3

Valuation, profit and volume

P/E (trailing)8.3Sector median 25.0
Market value$11.37BMedical Care Facilities
Profit margin8.0%Revenue growth +5.3%
Volume vs. 50-day0.8×Last 5 sessions

Source: Yahoo Finance, as of Nov 16, 2026. Volume and paper profit use daily closing prices.

Summary

Over the past 12 months, 0 Universal Health Services insiders reported open-market purchases totaling $0, while 1 insider reported sales totaling $128K. 0 of 5 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.

UHS earnings: how the stock reacted

Each quarterly results release (SEC 8-K Item 2.02), the trend before it, insider trades in the 30 days before, and the 2-day market reaction. “E” marks releases on the chart above.

Does it matter? →
Release15 days beforeInsiders, 30 days beforeReaction (2 days)Next 30 days
Jul 28, 2026 +2.4% None +5.6%S&P -1.3% +2.1%
Apr 28, 2026 -0.7% None -6.4%S&P -0.5% -13.0%
Feb 26, 2026 +8.4% None -10.7%S&P -1.0% -10.6%
Oct 28, 2025 +9.1% None +5.3%S&P +0.3% +8.1%
Jul 29, 2025 -15.1% None +6.8%S&P -0.4% +9.8%
Apr 29, 2025 -1.4% None +2.4%S&P +0.7% +7.5%
Feb 27, 2025 -3.1% None -2.7%S&P -0.1% +6.4%
Oct 25, 2024 +5.5% None -9.0%S&P +0.3% -0.5%

Most companies bar insiders from trading in the weeks before results, so pre-earnings purchases are rare and often made by directors or under pre-set plans. Past reactions don't predict future ones.

UHS short selling

Daily short-sale volume as a share of trading volume (FINRA), with the 20-day average.

20%40%60%2026-08-26: 77% of volume sold short2026-08-27: 65% of volume sold short2026-08-28: 48% of volume sold short2026-08-31: 52% of volume sold short2026-09-01: 67% of volume sold short2026-09-02: 69% of volume sold short2026-09-03: 69% of volume sold short2026-09-04: 85% of volume sold short2026-09-08: 76% of volume sold short2026-09-09: 82% of volume sold short2026-09-10: 58% of volume sold short2026-09-11: 71% of volume sold short2026-09-14: 64% of volume sold short2026-09-15: 79% of volume sold short2026-09-16: 71% of volume sold short2026-09-17: 76% of volume sold short2026-09-18: 78% of volume sold short2026-09-21: 77% of volume sold short2026-09-22: 66% of volume sold short2026-09-23: 84% of volume sold short2026-09-24: 68% of volume sold short2026-09-25: 84% of volume sold short2026-09-28: 71% of volume sold short2026-09-29: 90% of volume sold short2026-09-30: 86% of volume sold short2026-10-01: 84% of volume sold short2026-10-02: 80% of volume sold short2026-10-05: 57% of volume sold short2026-10-06: 76% of volume sold short2026-10-07: 73% of volume sold short2026-10-08: 77% of volume sold short2026-10-09: 72% of volume sold short2026-10-12: 66% of volume sold short2026-10-13: 62% of volume sold short2026-10-14: 69% of volume sold short2026-10-15: 63% of volume sold short2026-10-16: 70% of volume sold short2026-10-19: 67% of volume sold short2026-10-20: 51% of volume sold short2026-10-21: 46% of volume sold short2026-10-22: 56% of volume sold short2026-10-23: 61% of volume sold short2026-10-26: 67% of volume sold short2026-10-27: 70% of volume sold short2026-10-28: 75% of volume sold short2026-10-29: 80% of volume sold short2026-10-30: 70% of volume sold short2026-11-02: 77% of volume sold short2026-11-03: 73% of volume sold short2026-11-04: 68% of volume sold short2026-11-05: 72% of volume sold short2026-11-06: 81% of volume sold short2026-11-09: 59% of volume sold short2026-11-10: 62% of volume sold short2026-11-11: 66% of volume sold short2026-11-12: 70% of volume sold short2026-11-13: 73% of volume sold short2026-11-16: 65% of volume sold short2026-11-17: 55% of volume sold short2026-11-18: 61% of volume sold shortAug 26Sep 10Sep 24Oct 8Oct 22Nov 5
Latest (Nov 18): 61%20-day average: 69%Prior 2 months: 71%

This is short volume from off-exchange trades, not short interest. It includes market makers' routine hedging, so 40–50% is normal; what stands out is a ratio well above the stock's own average. Insiders buying while shorts pile in →

Members of Congress who traded UHS

From STOCK Act disclosures. Reported up to 45 days after the trade, in dollar ranges.

All Congress trades →
MemberTradeTradedReportedSince trade
Alan ArmstrongSenate Bought $1,001 - $15,000 Mar 27, 2026Jul 21, 2026 -4.3%

Insiders at Universal Health Services

InsiderBoughtSoldLast filingPast buys beat S&PScore
Warren J. NimetzDirector — $852K May 21, 2026 — —
Elliot J. Md Mba SussmanDirector — $346K May 21, 2026 — —
Alan B. MillerChair — — Nov 18, 2026 — —
Marc D. MillerCEO, President — — Nov 12, 2026 — —
Maria Ruderman SingerDirector — — May 21, 2026 — —
Eileen C. McDonnellDirector — — May 21, 2026 — —
Nina Chen-LangenmayrDirector — — May 21, 2026 — —
Steve FiltonCFO, President — — Mar 30, 2026 — —
Matthew Jay PetersonPresident — — Mar 30, 2026 — —
Edward H. SimPresident — — Mar 30, 2026 — —

Board links: companies that share insiders with UHS

Directors and executives who filed Form 4s for UHS and another company in the last 12 months.

See the map →
  • UHTUniversal Health Realty Income Trust Alan B. Miller Chair here · CEO, President at UHT · latest filing Nov 18, 2026

Insider activity at other Health Care companies

Same sector, ranked by insider buying in the last 90 days.

  • KODKodiak Sciences Inc.$181M bought
  • BBTXBambusa Therapeutics, Inc.$52.6M bought
  • WWBWINDWARD BIO GROUP AG$49.8M bought
  • ADRXADARx Pharmaceuticals, Inc.$43.4M bought
  • PEPGPepGen Inc.$43.1M bought
  • LYCALycia Therapeutics, Inc.$38.5M bought

UHS stock: common questions

Are Universal Health Services insiders buying UHS stock?

No. No Universal Health Services insider reported an open-market purchase of UHS in the past 12 months.

Are Universal Health Services insiders selling UHS stock?

1 insider reported sales worth $128K over the same period.

Where does this data come from?

Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.

What is UHS's P/E ratio?

UHS trades at about 8.3 times trailing earnings, compared with a median of 25.0 for the Health Care sector.

What is UHS's 52-week range?

Over the past year UHS has traded between $141.00 and $243.12. It last closed at $175.66 on Nov 19, 2026.